Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Environmental Science and Pollution Research International|December 26, 2022
Facile synthesis and comparative study of the enhanced photocatalytic degradation of two selected dyes by TiO2-g-C3N4 compositeAsma A Alothman, Asif Ayub, Safa K Hachim, et al.
Natural Product Research|November 3, 2025
Chemical composition and cytotoxic activity of Saudi Arabia Artemisia sieberi essential oilsTarik A Mohamed, Hazem A Albadry, Abd El-Nasser G El Gendy, et al.
Bioorganic Chemistry|July 4, 2025
Revisiting multi-pathway modulation with theophylline derivatives: Targeting STAT3, NF-κB, and apoptotic signaling in breast cancerOla S Afifi, Amira A Abdellatef, Heba A Abd El Razik, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|May 6, 2019
Cytotoxicity of 40 Egyptian plant extracts targeting mechanisms of drug-resistant cancer cellsMohamed-Elamir F Hegazy, Sara Abdelfatah, Ahmed R Hamed, et al.
Natural Product Research|August 1, 2019
New antimicrobial metabolites from the medicinal herb Artemisia herba-AlbaTarik A Mohamed, Abeer A Abd El Aty, Abdelaaty A Shahat, et al.
Journal of Hospital Medicine|December 12, 2024
Measuring the association between diagnostic errors and neighborhood disadvantageFarah A Kaiksow, Marina Brendel, Colin C Hubbard, et al.
Journal of Advanced Research|February 17, 2015
Microbial biotransformation as a tool for drug development based on natural products from mevalonic acid pathway: A reviewMohamed-Elamir F Hegazy, Tarik A Mohamed, Abdelsamed I ElShamy, et al.
Molecules (Basel, Switzerland)|January 21, 2023
Feature-Based Molecular Networking for the Exploration of the Metabolome Diversity of Common Egyptian Centaurea Species in Relation to Their Cytotoxic ActivityEman H Reda, Nesrine M Hegazi, Mona Marzouk, et al.
Chemistry & Biodiversity|July 6, 2026
Traditional Use, Phytochemistry, and Pharmacological Potential of Centaurea Genus: A Systematic ReviewEman H Reda, Tarik A Mohamed, Zienab T Abdel Shakour, et al.
Cancer Immunology, Immunotherapy : CII|September 20, 2011
A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patientsOsama E Rahma, Ed Ashtar, Malgorzata Czystowska, et al.
Pageof 9